Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × HIV Infections × Sodium Chloride × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 10 Neoplasms 5 Carcinoma, Non-Small-Cell Lung 4 Pain, Postoperative 3 Melanoma 3 Leukemia, Myeloid, Acute 3 Brain Neoplasms 3 Recurrence 2 Ovarian Neoplasms 2 Hemorrhage 2 Chronic Pain 2 Agnosia 2 Vulvodynia 1 Uterine Cervical Neoplasms 1 Stomatitis 1 Stomach Neoplasms 1 Spinal Cord Neoplasms 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Seizures 1 Radiodermatitis 1 Radiation Injuries 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Postoperative Complications 1 Peripheral Nervous System Diseases 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Parathyroid Neoplasms 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Pain, Intractable 1

Interventions

Doxorubicin 6 Vincristine 4 Liposomes 4 Bleomycin 4 Fluorouracil 3 Watchful Waiting 2 Light Coagulation 2 Imiquimod 2 sargramostim 1 Vaccines 1 Sodium Chloride 1 Papillomavirus Vaccines 1 Observation 1 Methotrexate 1 Leucovorin 1 Laser Therapy 1 Isotretinoin 1 Human Papillomavirus Recombinant Vaccine nonavalent 1 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1 Dexamethasone 1 Daunorubicin 1 Cytarabine 1 Cyclophosphamide 1 Circumcision, Male 1 Allopurinol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03284866 2026-01-28

COVENANT

AIDS Malignancy Consortium

Phase 3 Completed

HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡